UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 21, 2022
Accession Number:
Submission Type:
CIK: 0001719406
Company Name: NRX Pharmaceuticals, Inc.
File Number: 333-265492